JP2019131544A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019131544A5 JP2019131544A5 JP2019013745A JP2019013745A JP2019131544A5 JP 2019131544 A5 JP2019131544 A5 JP 2019131544A5 JP 2019013745 A JP2019013745 A JP 2019013745A JP 2019013745 A JP2019013745 A JP 2019013745A JP 2019131544 A5 JP2019131544 A5 JP 2019131544A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- formula
- acceptable salt
- diabetes
- compound represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023034806A JP2023071925A (ja) | 2018-02-01 | 2023-03-07 | 含窒素複素環アミド化合物及びその医薬用途 |
| JP2024094812A JP2024116307A (ja) | 2018-02-01 | 2024-06-12 | 含窒素複素環アミド化合物及びその医薬用途 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018016328 | 2018-02-01 | ||
| JP2018016328 | 2018-02-01 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023034806A Division JP2023071925A (ja) | 2018-02-01 | 2023-03-07 | 含窒素複素環アミド化合物及びその医薬用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019131544A JP2019131544A (ja) | 2019-08-08 |
| JP2019131544A5 true JP2019131544A5 (https=) | 2022-02-03 |
| JP7241556B2 JP7241556B2 (ja) | 2023-03-17 |
Family
ID=67479787
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019013745A Active JP7241556B2 (ja) | 2018-02-01 | 2019-01-30 | 含窒素複素環アミド化合物及びその医薬用途 |
| JP2023034806A Ceased JP2023071925A (ja) | 2018-02-01 | 2023-03-07 | 含窒素複素環アミド化合物及びその医薬用途 |
| JP2024094812A Pending JP2024116307A (ja) | 2018-02-01 | 2024-06-12 | 含窒素複素環アミド化合物及びその医薬用途 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023034806A Ceased JP2023071925A (ja) | 2018-02-01 | 2023-03-07 | 含窒素複素環アミド化合物及びその医薬用途 |
| JP2024094812A Pending JP2024116307A (ja) | 2018-02-01 | 2024-06-12 | 含窒素複素環アミド化合物及びその医薬用途 |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US10800784B2 (https=) |
| EP (1) | EP3747888A4 (https=) |
| JP (3) | JP7241556B2 (https=) |
| KR (1) | KR102725118B1 (https=) |
| CN (1) | CN111655692B (https=) |
| AR (1) | AR114237A1 (https=) |
| AU (1) | AU2019214048B2 (https=) |
| BR (1) | BR112020014177A2 (https=) |
| CA (1) | CA3090219A1 (https=) |
| CL (1) | CL2020002003A1 (https=) |
| CO (1) | CO2020009420A2 (https=) |
| IL (1) | IL276386B2 (https=) |
| MX (1) | MX2020008126A (https=) |
| MY (1) | MY205011A (https=) |
| PE (1) | PE20211273A1 (https=) |
| PH (1) | PH12020500613A1 (https=) |
| SA (1) | SA520412473B1 (https=) |
| SG (1) | SG11202006916SA (https=) |
| TW (1) | TWI803570B (https=) |
| WO (1) | WO2019151274A1 (https=) |
| ZA (1) | ZA202004548B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220362215A1 (en) | 2018-09-11 | 2022-11-17 | Japan Tobacco Inc. | Therapeutic or prophylactic agent for chronic kidney disease containing pyrazole-amide compound |
| CN110407744A (zh) * | 2019-08-13 | 2019-11-05 | 上海毕得医药科技有限公司 | 一种1-(4-氨基吡啶-2-基)乙酮的合成方法 |
| CN119841865A (zh) | 2020-02-07 | 2025-04-18 | 加舒布鲁姆生物公司 | 杂环glp-1激动剂 |
| PL4116301T3 (pl) * | 2020-03-04 | 2026-02-16 | Japan Tobacco Inc. | Skondensowany związek tricykliczny i jego zastosowanie medyczne |
| EP4211139A4 (en) * | 2020-09-10 | 2024-12-18 | Gasherbrum Bio, Inc. | HETEROCYCLIC GLP-1 AGONISTS |
| JP7599039B2 (ja) * | 2021-03-23 | 2024-12-12 | 上海海雁医薬科技有限公司 | 複素環置換ケトン類誘導体、その組成物および医薬における使用 |
| CN117897382A (zh) * | 2021-09-01 | 2024-04-16 | 日本烟草产业株式会社 | 含氮三环化合物及其药物用途 |
| AU2024222719A1 (en) | 2023-02-16 | 2025-08-21 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7943617B2 (en) * | 2006-11-27 | 2011-05-17 | Bristol-Myers Squibb Company | Heterobicyclic compounds useful as kinase inhibitors |
| WO2008132162A1 (en) | 2007-04-26 | 2008-11-06 | Boehringer Ingelheim International Gmbh | 3- (sulphonylamino) -phenyl-2 -hydroxy-ethylamino derivatives useful as beta-agonists, processes for preparing them and their use as medicaments |
| MX2009013130A (es) * | 2007-06-01 | 2010-01-15 | Schering Corp | Moduladores de gamma secretasa. |
| EP2090576A1 (en) * | 2008-02-01 | 2009-08-19 | Merz Pharma GmbH & Co.KGaA | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators |
| AR074797A1 (es) * | 2008-10-10 | 2011-02-16 | Japan Tobacco Inc | Compuesto de fluoreno , composiciones farmaceuticas , inhibidores de pdhk y pdhk2 , metodos de tratamiento , usos de los mismos y kit comercial |
| BR112013033098B8 (pt) | 2011-06-27 | 2021-03-23 | Alectos Therapeutics Inc | inibidores de glicosidade seletivos e usos dos mesmos |
| AU2012339870B2 (en) * | 2011-11-15 | 2017-06-29 | Merck Sharp & Dohme Corp. | Substituted cyclopropyl compounds useful as GPR119 agonists |
| PT2858986T (pt) * | 2012-06-12 | 2019-11-29 | Chong Kun Dang Pharmaceutical Corp | Derivados de piperidina como agonistas de gpr119 |
| CN103570725B (zh) | 2012-08-01 | 2017-03-22 | 中国科学院上海药物研究所 | 哌嗪并三唑类化合物及其制备方法和用途 |
| MY182884A (en) * | 2013-03-15 | 2021-02-05 | Japan Tobacco Inc | Pyrazole-amide compound and medicinal uses therefor |
| JP2015028009A (ja) * | 2013-07-01 | 2015-02-12 | 日本たばこ産業株式会社 | ピラゾール−アルコール化合物およびその医薬用途 |
| TW201536748A (zh) * | 2013-07-01 | 2015-10-01 | Japan Tobacco Inc | 茀－醯胺化合物及其醫藥用途 |
| GB201316823D0 (en) * | 2013-09-23 | 2013-11-06 | R & D Vernalis Ltd | New Chemical Entities |
| SG11201604940VA (en) | 2013-12-17 | 2016-07-28 | Merck Patent Gmbh | N1-(3,3,3-trifluoro-2-hydroxo-2-methylpropionyl)-piperidine derivatives as inhibitors of pyruvate dehydrogenase kinase |
| CA2994027C (en) | 2015-07-31 | 2023-10-10 | Merck Patent Gmbh | Bicyclic heterocyclic derivatives |
| JP6923551B2 (ja) | 2016-03-29 | 2021-08-18 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | ピルバートデヒドロゲナーゼキナーゼのインヒビターとしてのｎ１−（３，３，３−トリフルオロ−２−ヒドロキシ−２−メチルプロピオニル）−ピペリジン誘導体 |
| US10428024B2 (en) * | 2016-04-28 | 2019-10-01 | Merck Patent Gmbh | Piperidinyl derivatives |
| CN114716377A (zh) * | 2016-07-29 | 2022-07-08 | 日本烟草产业株式会社 | 吡唑-酰胺化合物的制造方法 |
| WO2018034918A1 (en) * | 2016-08-15 | 2018-02-22 | Merck Sharp & Dohme Corp. | Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease |
| MX2019004859A (es) | 2016-10-28 | 2019-06-20 | H Lundbeck As | Tratamientos de combinacion que comprenden la administracion de imidazopirazinonas. |
| RU2019109039A (ru) | 2016-10-28 | 2020-11-30 | Х. Лундбекк А/С | Комбинированные средства для лечения, предусматривающего введение имидазопиразинонов, предназначенные для лечения психических и/или когнитивных расстройств |
| PL4116301T3 (pl) * | 2020-03-04 | 2026-02-16 | Japan Tobacco Inc. | Skondensowany związek tricykliczny i jego zastosowanie medyczne |
| CN117897382A (zh) * | 2021-09-01 | 2024-04-16 | 日本烟草产业株式会社 | 含氮三环化合物及其药物用途 |
-
2019
- 2019-01-30 US US16/261,792 patent/US10800784B2/en active Active
- 2019-01-30 KR KR1020207024426A patent/KR102725118B1/ko active Active
- 2019-01-30 JP JP2019013745A patent/JP7241556B2/ja active Active
- 2019-01-30 WO PCT/JP2019/003052 patent/WO2019151274A1/ja not_active Ceased
- 2019-01-30 SG SG11202006916SA patent/SG11202006916SA/en unknown
- 2019-01-30 CN CN201980010396.9A patent/CN111655692B/zh active Active
- 2019-01-30 MX MX2020008126A patent/MX2020008126A/es unknown
- 2019-01-30 MY MYPI2020003575A patent/MY205011A/en unknown
- 2019-01-30 AU AU2019214048A patent/AU2019214048B2/en active Active
- 2019-01-30 PE PE2020001125A patent/PE20211273A1/es unknown
- 2019-01-30 AR ARP190100202A patent/AR114237A1/es unknown
- 2019-01-30 CA CA3090219A patent/CA3090219A1/en active Pending
- 2019-01-30 TW TW108103504A patent/TWI803570B/zh active
- 2019-01-30 EP EP19747660.9A patent/EP3747888A4/en active Pending
- 2019-01-30 BR BR112020014177-1A patent/BR112020014177A2/pt unknown
-
2020
- 2020-07-14 PH PH12020500613A patent/PH12020500613A1/en unknown
- 2020-07-21 SA SA520412473A patent/SA520412473B1/ar unknown
- 2020-07-22 ZA ZA2020/04548A patent/ZA202004548B/en unknown
- 2020-07-29 IL IL276386A patent/IL276386B2/en unknown
- 2020-07-29 CO CONC2020/0009420A patent/CO2020009420A2/es unknown
- 2020-07-30 CL CL2020002003A patent/CL2020002003A1/es unknown
- 2020-10-08 US US17/065,679 patent/US20210284644A1/en not_active Abandoned
-
2023
- 2023-03-07 JP JP2023034806A patent/JP2023071925A/ja not_active Ceased
- 2023-09-05 US US18/460,821 patent/US20240300952A1/en not_active Abandoned
-
2024
- 2024-06-12 JP JP2024094812A patent/JP2024116307A/ja active Pending
-
2025
- 2025-02-13 US US19/052,425 patent/US20260070910A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019131544A5 (https=) | ||
| JP2021516240A5 (https=) | ||
| JP2019094345A5 (https=) | ||
| JP2024050527A5 (https=) | ||
| JP2015524443A5 (https=) | ||
| JP2013545791A5 (https=) | ||
| JP2016500063A5 (https=) | ||
| JPWO2020103815A5 (https=) | ||
| RU98119885A (ru) | Фармацевтическая композиция, содержащая соединение, имеющее ангиотензин ii антагонистическую активность | |
| JP2017504640A5 (https=) | ||
| JP2019531320A5 (https=) | ||
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| JP2007527919A5 (https=) | ||
| JP2010516701A5 (https=) | ||
| RU2015144182A (ru) | Пиразоламидное соединение и его применения в медицине | |
| JP2010516702A5 (https=) | ||
| PH12020500613A1 (en) | Nitrogenated heterocyclic amide compound, and use thereof for medical purposes | |
| IL320810A (en) | Glucagon-like peptide 1 receptor agonists | |
| JP2019528279A5 (https=) | ||
| JPWO2021030556A5 (https=) | ||
| JP2022007994A5 (https=) | ||
| RU2015150614A (ru) | Новые 3, 4-дигидро-2н-изохинолин-1-оны и 2, 3-дигидро-изоиндол-1-оны | |
| JP2011524362A5 (https=) | ||
| JP2021530440A5 (https=) | ||
| RU2015149956A (ru) | Новые соединения 3,4-дигидро-2н-изохинолин-1-она и 2,3-дигидроизоиндол-1-она |